Observational Study on ADEM Outcome Predictors in Children
ClinicalTrials.gov Studies
Summary
The National Institutes of Health has registered an observational study (NCT07540182) aimed at determining outcome predictors in children diagnosed with acute disseminated encephalomyelitis (ADEM). The study will observe patients with ADEM, encephalomyelitis, and encephalopathy conditions. No new compliance obligations or regulatory requirements are established by this study registration.
What changed
NIH has added a new observational study registration (NCT07540182) to ClinicalTrials.gov. The study aims to determine outcome predictors in children diagnosed with acute disseminated encephalomyelitis (ADEM). Conditions under study include ADEM, encephalomyelitis, and encephalopathy.
Healthcare providers and clinical researchers working with pediatric neurological conditions may use the resulting data for clinical reference, but the study registration itself does not create any compliance obligations or regulatory requirements for any party.
Archived snapshot
Apr 20, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
The Aim of the Present Study is to Determine Outcome Predictors in Children Who Were Diagnosed as Acute Disseminated Encephalomyelitis (ADEM).
Observational NCT07540182 Kind: OBSERVATIONAL Apr 20, 2026
Abstract
The aim of the present study is to determine outcome predictors in children who were diagnosed as acute disseminated encephalomyelitis (ADEM).
Conditions: Acute Disseminated Encephalomyelitis, Encephalomyelitis, Encephalopathy
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.